AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Orchid Pharma Limited Call Transcript 2025

Aug 12, 2025

60526_rns_2025-08-12_f5395120-b030-4d8d-aee0-4d60b975b128.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [557 x 64] intentionally omitted <==

August 12, 2025

National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers,

Symbol: ORCHPHARMA Scrip Code: 524372

Ref: (i) Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (ii) SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024

Sub : Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited (“the Company”)

Dear Sir/Madam,

With reference to the above captioned subject and pursuant to Regulation 30, Subpara 15 of Para A Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and in continuation to earlier intimations dated August 07 & 12, 2025 for Analysts/ Investors Earnings Call, we would like to inform you that the Audio Recording of the Analysts/Investors Earnings Call held today i.e. August 12, 2025 at 04:30 P.M. (IST) to discuss the Unaudited Limited Reviewed Financial Results (Standalone and Consolidated) for the Quarter- I of Financial Year 2025-26, ended on June 30, 2025, has been uploaded on the website of the Company. Please find below the link to the Audio Recording of the same:

Link:

https://www.orchidpharma.com/downloads/Concall%20Audio%20recording%20Q1_J